Steven D. Harr, M.D., is a distinguished medical professional and business leader, currently serving as President, Chief Executive Officer, and Director at SANA BIOTECHNOLOGY INC. Dr. Harr brings a wealth of experience in the biotechnology and pharmaceutical industries, having held numerous leadership positions throughout his career. He earned his medical degree from a prestigious institution and has since dedicated his professional life to advancing medical research and patient care through innovative biotechnological solutions. At SANA BIOTECHNOLOGY INC., Dr. Harr plays a pivotal role in steering the company's strategic direction and operational execution. Under his leadership, the company has focused on developing cutting-edge therapies aimed at addressing unmet medical needs across various therapeutic areas. His vision for the company is to harness the power of biotechnology to create transformative treatments that can significantly improve patient outcomes. Dr. Harr's collaborative approach and deep understanding of the industry have been instrumental in fostering a culture of innovation and excellence within the organization. Throughout his career, Dr. Harr has been recognized for his contributions to the field of biotechnology. His achievements include spearheading the development of several groundbreaking therapies and leading successful clinical trials that have brought new treatments to market. His commitment to advancing science and medicine, combined with his strategic leadership, makes him an invaluable asset to SANA BIOTECHNOLOGY INC. and the broader biotechnology community.